In this editorial Sally Fischer (Genentech; CA, USA) explores ligand binding assay technologies: how to match the right tool to the bioanalytical challenge.
In this free on demand panel discussion, our experts provide insights into their own research with cellular and gene therapies including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.
In this interview Alex Hawes (LGC; Cambridge, UK) discusses the topic of immunogenicity. She explains how she developed her first anti-drug antibody analytical method and the platforms LGC use in their immunogenicity sector.
Find out more about the technologies involved in drug metabolism and what the future may hold for drug metabolism studies in drug discovery research in this ‘In the Zone’ feature.
The global CRO, PPD, have been announced as the best CRO provider at the World ADC Awards for advancing cancer research.